NDC 64842-0120 – Lytgobi
Futibatinib 4 mg/1 · Tablet · Oral
Product NDC64842-0120
Product details
- Brand name
- Lytgobi
- Generic name
- Futibatinib
- Labeler
- TAIHO PHARMACEUTICAL CO., LTD.
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- NDA · NDA214801
- Marketed since
- February 3, 2023
- Listing expires
- December 31, 2026
- Pharmacologic class
- Kinase Inhibitor
Active ingredients
- Futibatinib 4 mg/1
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 64842-0120-4 | 1 BLISTER PACK in 1 CARTON (64842-0120-4) / 21 TABLET in 1 BLISTER PACK | Feb 3, 2023 |
| 64842-0120-5 | 1 BLISTER PACK in 1 CARTON (64842-0120-5) / 28 TABLET in 1 BLISTER PACK | Feb 3, 2023 |
| 64842-0120-6 | 1 BLISTER PACK in 1 CARTON (64842-0120-6) / 35 TABLET in 1 BLISTER PACK | Feb 3, 2023 |
Other Lytgobi products
- 64842-0127 Futibatinib 16 mg/1 · Tablet · TAIHO PHARMACEUTICAL CO., LTD.
- 64842-0128 · Kit · TAIHO PHARMACEUTICAL CO., LTD.